Learn
Delve into dermatology diseases with new approaches from conventional to complementary care.
Topics
Explore a broad spectrum of dermatological conditions and topics to enhance your practice.
Training Programs
Expert led instruction for every level of patient care.
Log in to see enrolled program content.
Conferences
Gain practical insights and meet new colleagues.
Hover over a conference to view recordings.
Join Us
The largest integrative dermatology community.
This course focuses on the role of non-steroidal topical therapies in the treatment of vitiligo, with an emphasis on JAK inhibitors as a novel and targeted option for nonsegmental vitiligo. Learners will explore the immunologic mechanisms of action behind JAK inhibitors, assess efficacy and safety outcomes from pivotal clinical trials, and examine how these therapies compare to traditional steroid-based treatments. The course will also cover practical strategies for integrating JAK inhibitors into individualized treatment plans, including long-term disease control and patient monitoring considerations.
Learning Objectives:
- Describe the mechanism of action of JAK inhibitors and their use as non-steroidal topical therapies in vitiligo.
- Evaluate clinical trial data on the efficacy, safety, and long-term outcomes of topical JAK inhibitor therapy.
- Apply evidence-based strategies for initiating, monitoring, and maintaining JAK inhibitor treatment as part of a comprehensive, non-steroidal management approach to vitiligo.
Faculty
Dr. Erik Domingues, a board-certified Dermatologist, grew up in New Bedford, MA, graduating from New Bedford High School. He then graduated Summa Cum Laude from the University of Massachusetts – Dartmouth with a degree in Chemistry. He completed medical school at the University of Massachusetts Chan Medical School and an Internal Medicine Internship at St. Vincent Hospital – Worcester Medical Center. He completed his residency in Dermatology at the University of Massachusetts Chan Medical School in Worcester. He is also the founder and CEO of Modern Dermatology of Massachusetts in Fall River, MA.
Dr. Domingues is an Assistant Professor in Dermatology at the Department of Dermatology at the UMass Chan Medical School, helping train the next generation of Dermatologists. He volunteers extensively in the Southcoast community, including serving as chairman of the Southcoast Community Foundation Scholarship Committee. He has also previously served on the Southcoast Community Foundation’s board of directors. Since 2009, he has volunteered for the American Academy of Dermatology’s Camp Discovery in Pennsylvania, a camp for children with various skin disorders. He is currently one of the activities co-directors for the Camp that runs every August.
His previous research includes working on an educational intervention developed to enhance the ability and willingness of medical students to examine the skin for melanoma.
He specializes in surgical, cosmetic, and medical Dermatology with a special interest in complex medical dermatology including psoriasis, alopecia areata, eczema, hidradenitis suppurativa and vitiligo. He lectures regionally and nationally on these topics and enjoys seeing difficult to treat cases referred by other practices.
Editors
Dr. Song is the director of clinical research at Frontier Dermatology Partners. He is also a clinical instructor at the University of Washington and Silver Falls Dermatology. He specializes in inflammatory skin diseases, including psoriasis, atopic dermatitis, and hidradenitis suppurativa. Dr. Song is a regular contributor to the dermatology literature and speaks across the country as a key opinion leader.
